C4 Therapeutics, Inc. · NASDAQ:CCCC

Ra Capital Management, L.P. reported a 9.90% stake in C4 Therapeutics, Inc. (Schedule 13G)

Event Oct 17, 2025 · Filed Oct 24, 2025

Ra Capital Management, L.P. reported a 9.90% stake in C4 Therapeutics, Inc., 9,441,256 shares, as a passive investor on Oct 17, 2025. Filed Oct 24, 2025 (Schedule 13G).

Stake
9.90%
Shares
9,441,256
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%9,441,256
Peter Kolchinsky9.90%9,441,256
Rajeev Shah9.90%9,441,256
RA Capital Healthcare Fund, L.P.9.90%9,441,256

Source

View original at SEC

Related